Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a recent backend/software update behind the scenes.SummaryDifference0.0%

- Check18 days agoChange DetectedThe Taiwan site entry in the locations list was revised from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333.SummaryDifference0.0%

- Check26 days agoChange DetectedA new revision label was added, updating from v3.5.2 to v3.5.3. This reflects an updated revision of the document or system metadata.SummaryDifference0.0%

- Check33 days agoChange DetectedUpdated the Chile location text to use “Araucania” / “Temuco, Araucania, Chile” instead of “Región de la Araucanía” variants.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check62 days agoChange DetectedNaples, Italy, 80131 was added as a study location, replacing Napoli, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.